214
Participants
Start Date
June 23, 2015
Primary Completion Date
October 13, 2017
Study Completion Date
February 2, 2018
placebo
Matching placebo for risankizumab
risankizumab
Monoclonal IgG antibody
ULB Hopital Erasme, Brussels
Brussels - UNIV St-Luc, Brussels
UZ Leuven, Leuven
Centre Hospitalier Universitaire de Liège, Liège
Praxis Dr. Linnhoff, Berlin, Berlin
MECS Research GmbH, Berlin, Berlin
HOP Nord, Marseille
VA WNY Healthcare System, Buffalo
University of Pittsburgh Medical Center, Pittsburgh
Research Protocol Mgmt Spc, Pittsburgh
IFG Institut für Gesundheitsförderung GmbH, Rüdersdorf
Temple University School of Medicine, Philadelphia
Hamburger Institut für Therapieforschung GmbH (HIT), Hamburg
Chang Gung Memorial Hospital Keelung, Keelung
Johns Hopkins Hospital, Baltimore
O and O Alpan, LLC, Fairfax
KLB Gesundheitsforschung Lübeck GmbH, Lübeck
Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel
Wake Forest School of Medicine, Winston-Salem
American Health Research, Inc., Charlotte
Coastal Carolina Health Care, P.A., New Bern
MedTrial, LLC, Columbia
VitaLink Research, Greenville
Specjalistyczny Osrodek Alergologiczno-Intern. ALL-MED, Krakow
Praxis Dr. Hoffmann, Hannover, Hanover
Univ. Hospital in Krakow,Pulmonology Clinical Dept, Krakow
Clinical Research Trials of Florida, Inc., Tampa
HOP Arnaud de Villeneuve, Montpellier
HOP CHU de Grenoble, Grenoble
China Medical University Hospital, Taichung
HOP Nord Laënnec, Nantes
Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil gGmbH, Bochum
Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz
KPPK GmbH, Studienzentrum, Koblenz
Praxis Dr. med. Claus Keller, Frankfurt
IKF Pneumologie GmbH & Co. KG, Frankfurt
Medaimun GmbH, Frankfurt
Northwestern University, Chicago
Washington University School of Medicine, St Louis
Institut für klinische Forschung GmbH, Neu-Isenburg
Universitätsklinikum des Saarlandes, Homburg/Saar
HOP Bichat, Paris
Respiratory and Sleep Disorders Specialists, The Woodlands
IMMUNOe Research Centers, Centennial
Barlicki University Hospital No. 1, Lodz
WCCT Global, LLC, Costa Mesa
El Camino Hospital, Mountain View
Yale New Haven Hospital, New Haven
Brigham and Women's Hospital, Boston
Vancouver General Hospital, Vancouver
Burlington Lung Clinic, Burlington
Airway Inflammometry Laboratory, Hamilton
Leids Universitair Medisch Centrum (LUMC), Leiden
HagaZiekenhuis, The Hague
Gibinski Univ.Clin.Cnter of Silesian Med.Uni.Katowice,Outpat, Katowice
Barlicki University Hospital No. 1, Lodz
Chungbuk National University Hospital, Cheongju-si
Chonnam National University Hospital, Gwangju
Korea University Guro Hospital, Seoul
The Catholic University of Korea, St.Paul's Hospital, Seoul
Celerion Inc, Belfast
Bradford Royal Infirmary, Bradford
Glenfield Hospital, Leicester
The Medicines Evaluation Unit, Manchester
Wishaw General Hospital, Wishaw
Lead Sponsor
Collaborators (1)
Boehringer Ingelheim
INDUSTRY
AbbVie
INDUSTRY